FDA clears minimally invasive epicardial access system from CardioVia
April 8, 2025
CardioVia announced today that it received FDA clearance for its minimally invasive ViaOne epicardial access system.
CardioVia announced today that it received FDA clearance for its minimally invasive ViaOne epicardial access system.
Advanced Dosimetry Software Expands Capabilities for Personalized Radiopharmaceutical Therapies
Breakthrough Innovation Promises Superior Sensitivity and Precision in Radiation Detection Technologies
Insulet (Nasdaq:PODD) announced today that it commercially launched the Omnipod 5 automated insulin delivery (AID) system in Canada.
ICU Medical (Nasdaq: ICUI) announced today that it received FDA 510(k) clearance for several new additions to its infusion pump portfolio.
Satio announced today that it completed a Small Business Innovation Research (SBIR) contract for its intradermal drug delivery system.
New research on a cytokine called IL-17 adds to growing evidence that immune molecules can influence behavior during illness.
Provider groups and health systems warn tariffs will test healthcare’s fragile supply chain, and Wall Street said medtech businesses will face pressure, particularly diabetes tech firms.
The framework helps clinicians choose phrases that more accurately reflect the likelihood that certain conditions are present in X-rays.
Surmodics (Nasdaq:SRDX) announced today that it commercially launched the Pounce XL thrombectomy system for clot removal.